The Toxicologist - Society of Toxicology
The Toxicologist - Society of Toxicology
The Toxicologist - Society of Toxicology
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
191 Influence <strong>of</strong> Genetics on Paraoxonase 1 Activity in<br />
Monozygotic and Dizygotic Twins.<br />
L. Podolefsky 1 , K. M. Kelly 2 , J. C. Murray 3 , T. J. Raife 4 and G. Ludewig 1, 2 .<br />
1 Grad Program in Human <strong>Toxicology</strong>, University <strong>of</strong> Iowa, Iowa City, IA;<br />
2 Occupational and Environmental Health, University <strong>of</strong> Iowa, Iowa City, IA;<br />
3 Pediatrics, University <strong>of</strong> Iowa, Iowa City, IA; 4 Pathology, University <strong>of</strong> Iowa, Iowa<br />
City, IA.<br />
Paraoxonase 1 (PON1) is an important HDL-associated endogenous antioxidant<br />
found to play a major role in susceptibility to health effects from pesticides and oxidative<br />
stress. A number <strong>of</strong> gene polymorphisms influence both protein concentration<br />
and substrate specificity, as do certain lifestyle factors. However, reports about<br />
the influence <strong>of</strong> PON1 genetics have varied widely in the literature. <strong>The</strong> goal <strong>of</strong> this<br />
study was to examine the influence <strong>of</strong> genes and health data in a group <strong>of</strong> monozygotic<br />
and dizygotic twins to better understand the effect <strong>of</strong> genetics on PON1 activity<br />
levels. DNA, serum, and standard blood donation information was obtained<br />
from 6 sets <strong>of</strong> dizygotic twins and 13 sets <strong>of</strong> monozygotic twins. DNA was genotyped<br />
for polymorphisms within PON1, PON2, C-reactive protein (CRP), and<br />
tumor necrosis factor (TNF). PON1 activity was determined using phenyl acetate<br />
(PA) and CMPA [4-(Chloromethyl)phenyl acetate] as substrates, and genotyping<br />
was performed using the TaqMan-Applied Biosystems 7900 HT System. Using a<br />
general linear model, PON1 Q192R, L55M and C-108T were significantly associated<br />
with both PA and CMPA activity, with CMPA activity showing a stronger association<br />
with genetic variants. PON2 S311C was significantly associated with PA<br />
activity, but not CMPA. Activity for either substrate was not found to be associated<br />
with CRP or TNF polymorphisms. BMI was found to significantly correlate with<br />
CMPA activity, but not PA activity (correlation = -.34), while gender did not correlate<br />
with either substrate. Pair-wise analysis <strong>of</strong> all twins with identical PON genotypes<br />
showed no difference in PON activity variance between siblings, regardless <strong>of</strong><br />
zygosity. Though other shared or variant genetic and lifestyle factors may influence<br />
PON1 activity, the findings in this twin population suggest a strong link between<br />
PON activity and specific PON polymorphisms.<br />
192 Contribution <strong>of</strong> Environmental and Genetic Factors to<br />
Pancreatic Cancer.<br />
S. Chittiboyina, A. A. Bond, L. M. Kamendulis and B. A. Hocevar.<br />
Environmental Health, Indiana University School <strong>of</strong> Public Health, Bloomington, IN.<br />
Pancreatic cancer is the fourth leading cause <strong>of</strong> cancer deaths in the United States<br />
with a five year survival rate <strong>of</strong> less than 6%. Several environmental risk factors have<br />
been identified for pancreatic cancer, including dietary factors. In particular, high<br />
dietary intake <strong>of</strong> folate has been associated with a decreased incidence <strong>of</strong> pancreatic<br />
cancer, while low plasma folate levels are associated with an increased cancer risk. In<br />
conjunction with diet and lifestyle determinants, an individual’s folate pathway status<br />
is determined by their genetic makeup. In the present study, we determined the<br />
expression <strong>of</strong> selected SNPs in the folate metabolic pathway in a cohort <strong>of</strong> pancreatic<br />
cancer patients and healthy related and unrelated control groups. In agreement<br />
with other cancer studies, we show that cancer cases were more likely to express the<br />
TT allele <strong>of</strong> the methylene tetrahydr<strong>of</strong>olate reductase (MTHFR) C677T polymorphism<br />
compared to controls. Expression <strong>of</strong> this allele has been associated with low<br />
folate levels and elevated homocysteine (Hcy) levels. In support <strong>of</strong> this, we found<br />
that pancreatic cancer patients display elevated serum Hcy levels in comparison to<br />
both control groups. In addition, 48% <strong>of</strong> the pancreatic cancer patients exhibited<br />
hyperhomocysteinemia, as defined by a value >15 μM/L, (range 11.15 - 26.17<br />
μM/L), while no subjects in either control group exhibited hyperhomocysteinemia.<br />
In addition, we found that SNPs in betaine hydroxymethyltransferase (BHMT; rs<br />
3733890) and serine hydroxymethyl transferase (SHMT; rs 1979277) exhibited<br />
significantly different distributions between the case and control groups (p < 0.05).<br />
While a clear association was not seen between cancer risk and alcohol or smoking<br />
use in our population, self reported environmental exposure data suggested an association<br />
between pancreatic cancer and exposure to welding fumes. <strong>The</strong>se findings<br />
underlie the necessity to investigate further the interaction between environmental<br />
exposures and genetic factors which could provide further insight into the etiology<br />
<strong>of</strong> pancreatic cancer.<br />
193 <strong>The</strong> Impact <strong>of</strong> CYP2S1 Single Nucleotide Polymorphisms on<br />
the Metabolic Activation <strong>of</strong> the Anticancer Prodrug, AQ4N.<br />
N. Bajaj, N. M. Singh and A. M. Rowland. Chemistry and Biochemistry, NMSU,<br />
Las Cruces, NM.<br />
Cytochrome P450 2S1 (CYP2S1) is one <strong>of</strong> the most recent additions to the P450<br />
superfamily <strong>of</strong> enzymes. Although its physiological role has not yet been defined, it<br />
has been shown to influence metabolism <strong>of</strong> bioactive lipids, including<br />
40 SOT 2013 ANNUAL MEETING<br />
prostaglandins and retinoids. CYP2S1 is predominantly expressed in extra-hepatic<br />
epithelial cells. Its expression is elevated in cancer and catalyzes the metabolic activation<br />
<strong>of</strong> the anticancer prodrug, AQ4N, under hypoxic conditions. Interestingly<br />
our lab has also demonstrated that increased CYP2S1 expression may protect<br />
against AQ4 cytotoxicity under normoxic (21% O2) conditions. <strong>The</strong> main objective<br />
<strong>of</strong> this study is to determine whether individual variability in the CYP2S1 enzyme<br />
alters sensitivity <strong>of</strong> human lung cells to AQ4N and AQ4-mediated cytotoxicity.<br />
Five published CYP2S1 allelic variants have been published: CYP2S1*2<br />
(R380C), CYP2S1*3 (P466L), CYP2S1*4 (S61N), CYP2S1*5 (L230R).<br />
According to the NCBI database, two additional non-synonymous variants have<br />
been identified in cancer (A205T and L189F) and L189F is restricted to African<br />
American populations. We generate each <strong>of</strong> the polymorphisms in a CYP2S1-Flag<br />
mammalian expression vector, using site directed mutagenesis. Thus far, two stable<br />
lines (S61N and L189F) in bronchial epithelial cells (BEAS-2B) and four stable<br />
(S61N, R166H, A205T, and P466L) alveolar carcinoma cell lines (A549) have<br />
been made. Examination <strong>of</strong> AQ4N and AQ4 cytotoxicity in BEAS-2B cells revealed<br />
that both mutants (S61N and L189F) exhibit significantly increased cytotoxicity<br />
in response to AQ4N compared with wild type CYP2S1-Flag and<br />
pcDNA3.1 controls. Interestingly, the S61N polymorphism was significantly more<br />
sensitive to AQ4 than any <strong>of</strong> the other cell lines. This effect appears to be selective<br />
because cytotoxicity is not altered in response to a similar topoisomerase II inhibitor,<br />
mitoxantrone. We are currently testing the effects <strong>of</strong> these polymorphisms<br />
on AQ4N and AQ4 levels, using HPLC. Research funded by NIH NIGMS Grant<br />
# R25GM061222.<br />
194 <strong>The</strong> Remarkable Genotoxic Effect <strong>of</strong> Exposure to Ethyl<br />
Tertiary Butyl Ether in ALDH2 Knockout Mice.<br />
R. Wang, Z. Weng, K. Ohtani, M. Suda, Y. Yanagiba and T. Suzuki. Japan<br />
National Institute <strong>of</strong> Occupational Safety and Health, Kawasaki, Japan.<br />
Ethyl Tertiary Butyl Ether (ETBE) is used in gasoline for vehicles as a bi<strong>of</strong>uel.<br />
ETBE exposure induced liver damage and other health effects only at high concentrations<br />
in our previous studies, and its No Observed Adverse Effect Level<br />
(NOAEL) was calculated to be 500 ppm. However, in mice without ALDH2 enzyme<br />
activity, ETBE could induce DNA damage even at the NOAEL. To find out<br />
how low concentration at which ETBE shows its genotoxic effect, we did the exposure<br />
experiment with mice at low range <strong>of</strong> ETBE concentrations. METHODS:<br />
Male Aldh2-/- (KO), Aldh2+/- (HT) as well as C57BL/6 strain (WT), at 8 weeks<br />
old were exposed to ETBE at 0, 50, 200 and 500 ppm, 6 hr/day and 5 days/week,<br />
for 9 weeks. Blood, liver, epididymides were sampled 20 hr after the last exposure,<br />
and DNA damages were analyzed with comet assay in these tissues. RESULTS: <strong>The</strong><br />
tail intensity (TI) was used to evaluate the degree <strong>of</strong> DNA damage. In the leukocytes<br />
<strong>of</strong> WT mice, the TI value was not affected in any exposure group as compared<br />
to the control. However, the TI was significantly increased in 200 and 500 ppm<br />
groups <strong>of</strong> KO mice. Similar results were also obtained in HT mice, but there was<br />
no difference between the two types <strong>of</strong> mice. In liver cells and sperm, ETBE also induced<br />
DNA damage, but this effect was only observed in KO and HT mice as in<br />
the leukocytes. <strong>The</strong> NOAEL was 50 ppm in these types <strong>of</strong> mice. <strong>The</strong>se results suggest<br />
that ALDH2 deficiency may increase the susceptibility to the health effect <strong>of</strong><br />
ETBE exposure. We thank Ms. S. Watanabe for her assistance in the manipulation<br />
<strong>of</strong> the animals.<br />
195 MGMT Haplotypes Alter MGMT Expression and Can Thus<br />
Affect Response to Alkylating Agents.<br />
M. Xu, I. Nekhayeva, C. E. Cross, C. M. Rondelli and S. Z. Abdel-Rahman.<br />
OB/Gyn, UTMB, Galveston, TX.<br />
Glioblastoma (GB) is rapidly fatal. However, treatment with temozolomide (TMZ)<br />
and radiation is beneficial, but only for some patients. TMZ alkylates tumor DNA<br />
to form O6-alkylguanine (O6-AG) DNA adducts, inducing apoptosis. Because<br />
O6-AG is repaired by O6-methylguanine-DNA methyltransferase (MGMT), levels<br />
<strong>of</strong> MGMT are critical in determining tumor response to TMZ. Single nucleotide<br />
polymorphisms (SNPs) in the promoter/enhancer (P/E) region <strong>of</strong> the MGMT gene<br />
can alter its transcription and thus alter MGMT protein levels. Genetic variants are<br />
not arrayed as individual SNPs but as combinations forming specific “haplotypes”.<br />
To date, no studies have determined the haplotypes structure <strong>of</strong> the P/E region <strong>of</strong><br />
MGMT or their effect on its transcription. We sequenced 104 DNA samples from<br />
healthy individuals and identified 8 SNPS in this region (7/Y, 135/K, 290 /R,<br />
485/M, 575/M, 666/R, 777/M and 1099/Y). Using bioinformatics, we inferred<br />
the haplotypes encompassing these SNPs. We identified 21 potential haplotypes<br />
ranging in frequency from 0.39 to 0.00005, <strong>of</strong> which 10 were identified in our<br />
sample population as 20 paired haplotype combinations. We hypothesized that<br />
these haplotypes alter the regulation <strong>of</strong> MGMT transcription. Luciferase-reporter<br />
constructs containing different MGMT haplotypes were transfected into a GB cell